Newsworthy

Crohn’s Disease Clinical Trial Recruitment

The AFFIRM Study is looking for adults who are 18 years of age or older, with moderate to severe Crohn’s disease (CD). The study is researching a study drug to see if it can safely be given subcutaneously (an injection under the skin) with the goal of inducing “remission” in adults with CD. Remission is the point where CD symptoms start to go away or disappear completely. To see whether you might be eligible, please visit our website www.AFFIRMstudyCD.com, or contact the Cotton O’Neil Digestive Health Clinical Research Center to learn more: (785) 270-4856.

Posted in

In Other News

Stormont Vail Community News Oct. 21, 2025

svh_generic_tb_2025

2025 Stormont Vail Health Trauma and Critical Care Symposium Focused on Mass Casualty Response

091625b

We Celebrate Brett Baker DAISY Award Recipient

Daisy_Brett Baker5 SVnews StormConn

We Celebrate at Gary’s Farm Festival 2025

2025 Wrap Up - Garys Farm Fest_X

Stormont Vail Health Welcomes Laura Vanderheiden-Zahner, M.D., to Family Medicine Team

laura_vanderheiden-zahner_tb